Tilray Brands, Inc. Payments to Acquire Investments
Tilray Brands, Inc. (TLRY) reported Payments to Acquire Investments of $1.35 billion for the 12-month period ending 2019-12-31, per its 10-K filed 2021-02-19.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireInvestments · last filed 2021-02-19
- Tilray Brands, Inc. payments to acquire investments for the quarter ending 2019-12-31 was $1.34B, a 387.51% increase year-over-year.
- Tilray Brands, Inc. payments to acquire investments for the quarter ending 2019-09-30 was $106.00K, a 99.28% decline year-over-year.
- Tilray Brands, Inc. payments to acquire investments for the quarter ending 2019-06-30 was $5.47M.
- Tilray Brands, Inc. payments to acquire investments for the quarter ending 2019-03-31 was $2.91M, a 90.16% decline year-over-year.
- Tilray Brands, Inc. payments to acquire investments for fiscal 2019 was $1.35B, a 322.91% increase from fiscal 2018.
- Tilray Brands, Inc. payments to acquire investments for fiscal 2018 was $319.37M.
| Period end | Payments to Acquire Investments 3 month | Payments to Acquire Investments 6 month | Payments to Acquire Investments 9 month | Payments to Acquire Investments 12 month |
|---|---|---|---|---|
| 2019-12-31 | $1.34B derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19 | $1.34B derived: sum of 2 quarters · filed 2021-02-19 | $1.35B derived: sum of 3 quarters · filed 2021-02-19 | $1.35B 10-K · filed 2021-02-19 |
| 2019-09-30 | $106.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $5.57M derived: sum of 2 quarters · filed 2020-11-09 | $8.49M 10-Q · filed 2020-11-09 | $283.80M derived: sum of 4 quarters · filed 2021-02-19 |
| 2019-06-30 | $5.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $8.38M 10-Q · filed 2020-08-10 | $283.69M derived: sum of 3 quarters · filed 2021-02-19 | $298.36M derived: sum of 4 quarters · filed 2021-02-19 |
| 2019-03-31 | $2.91M 10-Q · filed 2020-05-11 | $278.23M derived: sum of 2 quarters · filed 2021-02-19 | $292.89M derived: sum of 3 quarters · filed 2021-02-19 | $292.66M derived: sum of 4 quarters · filed 2021-02-19 |
| 2018-12-31 | $275.31M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19 | $289.98M derived: sum of 2 quarters · filed 2021-02-19 | $289.75M derived: sum of 3 quarters · filed 2021-02-19 | $319.37M 10-K · filed 2021-02-19 |
| 2018-09-30 | $14.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | $14.44M derived: sum of 2 quarters · filed 2019-11-13 | $44.06M 10-Q · filed 2019-11-13 | |
| 2018-06-30 | -$230.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | $29.39M 10-Q · filed 2019-08-13 | ||
| 2018-03-31 | $29.62M 10-Q · filed 2019-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |